Toggle Main Menu Toggle Search

ePrints

Browsing publications by Professor Philip Home

Newcastle AuthorsTitleYearFull text
Professor Philip Home
Cardiovascular outcome trials of glucose-lowering medications: an update2019
Professor Philip Home
Commencing insulin glargine 100 U/mL therapy in individuals with type 2 diabetes: Determinants of achievement of HbA1c goal less than 7.0%2019
Professor Philip Home
Determination of fasiglifam-induced liver toxicity: Insights from the data monitoring committee of the fasiglifam clinical trials program2019
Professor Philip Home
The Need for Accuracy in Hemoglobin A1c Proficiency Testing: Why the Proposed CLIA Rule of 2019 Is a Step Backward2019
Professor Philip Home
2020 vision – An overview of prospects for diabetes management and prevention in the next decade2018
Professor Philip Home
A randomized, double-blind trial evaluating the efficacy and safety of monotherapy with the once-weekly dipeptidyl peptidase-4 inhibitor omarigliptin in people with type 2 diabetes2018
Professor Philip Home
Anti-Insulin Antibodies and Adverse Events with Biosimilar Insulin Lispro Compared with Humalog Insulin Lispro in People with Diabetes2018
Professor Philip Home
Assessment of hypoglycaemia during basal insulin therapy: Temporal distribution and risk of events using a predefined or an expanded definition of nocturnal events2018
Professor Philip Home
Clinical correlates of hypoglycaemia over 4 years in people with type 2 diabetes starting insulin: An analysis from the CREDIT study2018
Professor Philip Home
Comment on Novodvorsky et al. Diurnal Differences in Risk of Cardiac Arrhythmias During Spontaneous Hypoglycemia in Young People With Type 1 Diabetes. Diabetes Care 2017;40:655–6622018
1234567891011121314151617181920...